HIV-1 Ribonuclease H: Structure, Catalytic Mechanism and Inhibitors
Open accessThe DOI matches its Crossref record; 107 of the 108 references it cites were found in a registry or an index.
Abstract
Since the human immunodeficiency virus (HIV) was discovered as the etiological agent of acquired immunodeficiency syndrome (AIDS), it has encouraged much research into antiviral compounds. The reverse transcriptase (RT) of HIV has been a main target for antiviral drugs. However, all drugs developed so far inhibit the polymerase function of the enzyme, while none of the approved antiviral agents inhibit specifically the necessary ribonuclease H (RNase H) function of RT. This review provides a background on structure-function relationships of HIV-1 RNase H, as well as an outline of current attempts to develop novel, potent chemotherapeutics against a difficult drug target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2. A Crystal structure of HIV-1 RT (PDB code: 1RTD. The p51 subunit is shown in orange, while the p66 subunit is divided into the fingers (cyan), connection (blue) and RNase H (grey) subdomains. The residues of the conserved DEDD motif are shown and red and marked with arrows. B Crystal structures of the RNase H domain of HIV-1 RT (PDB code:1RTD) [5], human RNase H1 (PDB code: 2QKB) [12] and E. coli RNase H1 (PBD code: 1WSJ). All three show the same mixed beta-sheet with asymmetric alpha helices, while the human and E. coli RNases H contain the C-helix, or basic loop.](https://figures.cochat.ai/paper-figures/b63df9a426c04092bf0ff917330c098e/hiv-1-ribonuclease-h-structure-catalytic-mechanism-and-inhibitors-figure-2.jpg)



![Figure 6. A During (−)-strand DNA synthesis, the PPT region of the RNA genome is resistant to RNase H cleavage, while a portion of the RNA genome is degraded concomitantly with (−)-strand DNA synthesis. Here, a specific cleavage is made to create the PPT primer. B The RNase H-resistant PPT sequence forms the primer for (+)-strand DNA synthesis when the rest of the genome is completely degraded by RNase H. C The RNA primer is extended 12 nucleotides, D then RT pauses and changes orientations to a polymerase-independent binding mode in order to cleave at the DNA:RNA junction, and remove the PPT primer. E The 12-mer fragment is extended toward the 5′ end of the (−)-strand DNA (see Figure 1F). After the second strand transfer event, the (+)-strand DNA is fully synthesized resulting in a fully double-stranded provirus. Adapted from [49].](https://figures.cochat.ai/paper-figures/20a118ca091245829bbec2fa00a9968d/hiv-1-ribonuclease-h-structure-catalytic-mechanism-and-inhibitors-figure-6.jpg)
![Figure 7. Examples of the main classes of small molecule inhibitors against HIV-1 RT-associated RNase H activity. A N-hydroxyimides. Developed from influenza inhibitors and among the first to use the 3-oxygen pharmacophore [84]. B Pyrimidinol carboxylic acid derivatives [85]. Potent inhibitors based on the successful scaffold of the metal-chelating active site inhibitors. C Diketo acid derivatives are also active in some cases against the viral integrase. RDS1643 shown here is the only diketo acid to have antiviral activity in vivo [86]. D The vinylogous ureas (NSC727447 pictured here) represent a different kind of inhibitor that binds allosterically near the p51 thumb [87]. E N-acyl hydrazones appear to bind to multiple binding sites depending on the specific inhibitor, including the RNase H domain and a site that overlaps the NNRTI binding pocket (DHBNH picture above) [88]. F Hydroxylated tropolones (β-thujaplicinol pictured here) are the subject of several studies that have provided the basis for a biochemical mechanism of inhibition by active site RNase H inhibitors [39,89,90].](https://figures.cochat.ai/paper-figures/3e3e02f115734f71b03c1cf5be0d88d9/hiv-1-ribonuclease-h-structure-catalytic-mechanism-and-inhibitors-figure-7.jpg)
![Figure 8. A schematic of possible models of active site inhibitor binding, based on studies with the tropolone derivative β-thujaplicinol (blue sphere) [39,90]. Evidence suggests that the inhibitor is unable to bind to an enzyme-substrate (E-S) complex (top left), only to free enzyme forming (top right) and enzyme-inhibitor (E-I) complex (bottom right). However, the substrate might be able to bind to this E-I complex, forming an E-S-I complex that is not productive with respect to RNase H cleavage (bottom left). As suggested by Himmel et al., the inhibitor occupies the position normally claimed by the scissile phosphate [90]. As such, it is possible that the substrate undergoes a change in trajectory in relation to the scissile phosphate and the RNase H active site [39]. Then eventually, the inhibitor dissociates and RT is allowed to cleave the uninhibited substrate (E-S complex, top left).](https://figures.cochat.ai/paper-figures/1c9b6865dd434338935d8adfac6655d4/hiv-1-ribonuclease-h-structure-catalytic-mechanism-and-inhibitors-figure-8.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Based on these structural and functional experiments, the two metal-binding mechanism has been widely accepted [27,28,30,31,63,64].”
From Retroviral RNase H: structure, mechanism, and inhibition (2021) · cites this paper as [30]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor
Kohlstaedt, L. A., Wang, J., Friedman, J. M., Rice, P. A., & Steitz, T. A. (1992) · Science · doi:10.1126/science.1377403 · Cited by 1,914 · cited 1×
“the non-nucleoside binding pocket, a hydrophobic depression created by the binding of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and located near the base of the p66 thumb subdomain, about 10 Å from the polymerase active site [4,64,65].”
BackgroundHuang, H., Chopra, R., Verdine, G. L., & Harrison, S. C. (1998) · Science · doi:10.1126/science.282.5394.1669 · Cited by 1,420
Inhibitors of Strand Transfer That Prevent Integration and Inhibit HIV-1 Replication in Cells
Hazuda, D. J., Felock, P., Witmer, M., Wolfe, A., Stillmock, K., Grobler, J. A., Espeseth, A., Gabryelski, L., Schleif, W., Blau, C., et al. (2000) · Science · doi:10.1126/science.287.5453.646 · Cited by 1,131 · cited 1×
“Diketo acids also form a group of compounds initially developed against the structurally similar HIV-1 integrase (IN) [92,93].”
BackgroundJacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115 · cited 2×
“B-form geometry near the RNase H active site [6].”
BackgroundAnti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV.
De Clercq, E. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.10.010 · Cited by 627 · cited 2×
“There are currently 25 compounds in clinical use to treat HIV [2].”
BackgroundNowotny, M., Gaidamakov, S. A., Crouch, R. J., & Yang, W. (2005) · Cell · doi:10.1016/j.cell.2005.04.024 · Cited by 620 · cited 3×
“halodurans ) [9-11] and eukaryotic (human) [12] RNases H, and is part of the superfamily of polynucleotidyl transferases.”
BackgroundMaking and Breaking Nucleic Acids: Two-Mg2+-Ion Catalysis and Substrate Specificity
Yang, W., Lee, J. Y., & Nowotny, M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.03.013 · Cited by 573 · cited 1×
“This has led to the general acceptance of a two-metal ion mechanism for retroviral RNase H hydrolysis [11,12,17].”
BackgroundCrystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase
Davies, J. F., Hostomska, Z., Hostomsky, Z., Jordan, S. R., & Matthews, D. A. (1991) · Science · doi:10.1126/science.1707186 · Cited by 570 · cited 2×
“In the case of HIV-1 RT, the RNase H domain constitutes the C-terminus of the p66 subunit, which is missing in p51, due to cleavage by the viral protease [3-7].”
BackgroundHigh resolution structures of HIV-1 RT from four RT–inhibitor complexes
Ren, J., Esnouf, R., Garman, E., Somers, D., Ross, C., Kirby, I., Keeling, J., Darby, G., Jones, Y., Stuart, D., et al. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0495-293 · Cited by 502 · cited 1×
“the non-nucleoside binding pocket, a hydrophobic depression created by the binding of non-nucleoside reverse transcriptase inhibitors (NNRTIs) and located near the base of the p66 thumb subdomain, about 10 Å from the polymerase active site [4,64,65].”
BackgroundMechanism and fidelity of HIV reverse transcriptase.
Kati, W. M., Johnson, K. A., Jerva, L. F., & Anderson, K. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35706-5 · Cited by 492 · cited 1×
“In the presence of deoxyribonucleotides (dNTPs) RT will advance and RNase H will eventually continue to cut the template; however, the rate of RNase H cleavage is approximately seven times slower than polymerization [33].”
BackgroundStructure of ribonuclease H phased at 2 a resolution by MAD analysis of the selenomethionyl protein
Yang, W., Hendrickson, W. A., Crouch, R. J., & Satow, Y. (1990) · Science · doi:10.1126/science.2169648 · Cited by 473 · cited 1×
“halodurans ) [9-11] and eukaryotic (human) [12] RNases H, and is part of the superfamily of polynucleotidyl transferases.”
BackgroundCrystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA:DNA
Sarafianos, S. G., Das, K., Tantillo, C., Clark, A. D., Ding, J., Whitcomb, J. M., Boyer, P. L., Hughes, S. H., & Arnold, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1449 · Cited by 411 · cited 11×
“When RT is bound to a DNA/DNA substrate, the nucleic acid adopts A-form geometry near the polymerase active site, and B-form geometry near the RNase H active site [6].”
BackgroundInfluentialBushman, F. D., & Craigie, R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.4.1339 · Cited by 410 · cited 1×
“Integrase has been shown to recognize diverse structures as substrates for 3’ processing and strand transfer [62].”
BackgroundGrobler, J. A., Stillmock, K., Hu, B., Witmer, M., Felock, P., Espeseth, A. S., Wolfe, A., Egbertson, M., Bourgeois, M., Melamed, J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092056199 · Cited by 399 · cited 1×
“Diketo acids also form a group of compounds initially developed against the structurally similar HIV-1 integrase (IN) [92,93].”
BackgroundThree-dimensional structure of ribonuclease H from E. coli
Katayanagi, K., Miyagawa, M., Matsushima, M., Ishikawa, M., Kanaya, S., Ikehara, M., Matsuzaki, T., & Morikawa, K. (1990) · Nature · doi:10.1038/347306a0 · Cited by 349
Ding, J., Das, K., Hsiou, Y., Sarafianos, S. G., Clark, A. D., Jacobo-Molina, A., Tantillo, C., Hughes, S. H., & Arnold, E. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2208 · Cited by 321 · cited 2×
“In the case of HIV-1 RT, the RNase H domain constitutes the C-terminus of the p66 subunit, which is missing in p51, due to cleavage by the viral protease [3-7].”
BackgroundStructure of Human RNase H1 Complexed with an RNA/DNA Hybrid: Insight into HIV Reverse Transcription
Nowotny, M., Gaidamakov, S. A., Ghirlando, R., Cerritelli, S. M., Crouch, R. J., & Yang, W. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.08.015 · Cited by 316 · cited 7×
“halodurans and human RNases H show two magnesium ions [11,12], which is also supported by biochemical evidence of related enzymes [16].”
BackgroundInfluentialNowotny, M., & Yang, W. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601076 · Cited by 250 · cited 2×
“5 to 4 Å from each other, possibly with some degree of flexibility (Figure 3) [18].”
BackgroundA model for the mechanism of polymerase translocation 1 1Edited by A. R. Fersht
Guajardo, R., & Sousa, R. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0707 · Cited by 202 · cited 1×
“Biochemical evidence suggests that RT can oscillate back and forth between pre- and post-translocational positions in a thermodynamic equilibrium that is sequence specific [34-38].”
BackgroundStrand transfer events during HIV-1 reverse transcription
Basu, V. P., Song, M. S., Gao, L., Rigby, S. T., Hanson, M. N., & Bambara, R. A. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.017 · Cited by 201 · cited 2×
“Models of the strand transfer reactions have been reviewed elsewhere [55].”
BackgroundStructures of HIV-1 reverse transcriptase with pre- and post-translocation AZTMP-terminated DNA
Sarafianos, S. G. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf637 · Cited by 199
Dynamic binding orientations direct activity of HIV reverse transcriptase
Abbondanzieri, E. A., Bokinsky, G., Rausch, J. W., Zhang, J. X., Le Grice, S. F. J., & Zhuang, X. (2008) · Nature · doi:10.1038/nature06941 · Cited by 186 · cited 4×
“, polymerization or RNA hydrolysis [47].”
BackgroundInfluentialFurfine, E. S., & Reardon, J. E. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52449-2 · Cited by 181 · cited 1×
“Per definition, this specific cut is known as polymerase-dependent RNase H activity [21,28-32].”
BackgroundBudihas, S. R. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki268 · Cited by 180 · cited 6×
“This competitive mode of inhibition is in apparent contrast to previously published results on β-thujaplicinol and other active site inhibitors [86,89].”
BackgroundResultInfluentialGopalakrishnan, V, Peliska, J. A., & Benkovic, S. J. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10763 · Cited by 175 · cited 1×
“Per definition, this specific cut is known as polymerase-dependent RNase H activity [21,28-32].”
BackgroundYap, S.-H., Sheen, C.-W., Fahey, J., Zanin, M., Tyssen, D., Lima, V. D., Wynhoven, B., Kuiper, M., Sluis-Cremer, N., Harrigan, P. R., et al. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040335 · Cited by 162 · cited 5×
“AZT also selects for other connection/RNase H domain mutants such as A360I/V, A371V and Q509L [67-73].”
BackgroundInfluentialShaw-Reid, C. A., Munshi, V., Graham, P., Wolfe, A., Witmer, M., Danzeisen, R., Olsen, D. B., Carroll, S. S., Embrey, M., Wai, J. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200621200 · Cited by 156 · cited 4×
“However, despite effectively inhibiting RNase H activity in vitro , this compound did not show inhibition of viral replication in cell culture [94].”
BackgroundInfluentialKlumpp, K. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg881 · Cited by 151 · cited 5×
“coli RNase H1 which, in contrast to the 2-metal ion mechanism of HIV RNase H, uses a 1-metal ion activation/attenuation mechanism, further distancing itself from the active site inhibitors [16,97,98].”
BackgroundInfluentialRNase H activity: structure, specificity, and function in reverse transcription
Schultz, S. J., & Champoux, J. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.007 · Cited by 150 · cited 1×
“The other form of polymerase-independent RNase H cleavage is called 5’-end directed cleavage, and occurs on fragments of RNA recessed on a longer DNA strand [44].”
BackgroundUse of a Pharmacophore Model To Discover a New Class of Influenza Endonuclease Inhibitors
Parkes, K. E. B., Ermert, P., Fässler, J., Ives, J., Martin, J. A., Merrett, J. H., Obrecht, D., Williams, G., & Klumpp, K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm020334u · Cited by 145 · cited 1×
“endonuclease [83], as well as several other compounds acting through a different mechanism.”
BackgroundHimmel, D. M., Sarafianos, S. G., Dharmasena, S., Hossain, M. M., McCoy-Simandle, K., Ilina, T., Clark, A. D., Knight, J. L., Julias, J. G., Clark, P. K., et al. (2006) · ACS Chemical Biology · doi:10.1021/cb600303y · Cited by 140 · cited 3×
“E N-acyl hydrazones appear to bind to multiple binding sites depending on the specific inhibitor, including the RNase H domain and a site that overlaps the NNRTI binding pocket (DHBNH picture above) [88].”
BackgroundInfluentialHimmel, D. M., Maegley, K. A., Pauly, T. A., Bauman, J. D., Das, K., Dharia, C., Clark, A. D., Ryan, K., Hickey, M. J., Love, R. A., et al. (2009) · Structure · doi:10.1016/j.str.2009.09.016 · Cited by 140 · cited 6×
“This model would likewise be in agreement with classical non-competitive kinetics measured under steadystate conditions [39,89,90].”
BackgroundResultInfluentialNikolenko, G. N., Delviks-Frankenberry, K. A., Palmer, S., Maldarelli, F., Fivash, M. J., Coffin, J. M., & Pathak, V. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609642104 · Cited by 136 · cited 1×
“Therefore, decreased RNase H activity could act to increase the half-life of the template, allowing more time for RT to excise AZT at the primer terminus [67,74-78].”
BackgroundNikolenko, G. N., Palmer, S., Maldarelli, F., Mellors, J. W., Coffin, J. M., & Pathak, V. K. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409823102 · Cited by 131 · cited 1×
“Therefore, decreased RNase H activity could act to increase the half-life of the template, allowing more time for RT to excise AZT at the primer terminus [67,74-78].”
BackgroundHuber, H. E., & Richardson, C. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)86984-8 · Cited by 127 · cited 1×
“A purine-rich sequence (5’ AAAAGAAAAGGGGGG 3’) called the polypurine tract (PPT) located just 5’ to the U3 sequence of the genome is resistant to RNase H cleavage and remains intact after the rest of the viral RNA has been removed (RNase H makes a specific cut following the 6th “G” residue to define the 3’ end of the…”
BackgroundTramontano, E., Esposito, F., Badas, R., Santo, R. D., Costi, R., & Colla, P. L. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2004.11.002 · Cited by 121 · cited 5×
“RDS1643 shown here is the only diketo acid to have antiviral activity in vivo [86].”
BackgroundResultInfluentialLoya, S., Tal, R., Kashman, Y., & Hizi, A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.10.2009 · Cited by 114 · cited 1×
“There have been many other compounds described in the literature that show apparent inhibition of RNase H activity, including natural products such as various quinones and napthoquinone derivatives, although many of these suffer from a lack of potency [103,104].”
BackgroundGrobler, J. A., Dornadula, G., Rice, M. R., Simcoe, A. L., Hazuda, D. J., & Miller, M. D. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608274200 · Cited by 109 · cited 1×
“Recent evidence has suggested that the initiation of (+)-strand synthesis is preferentially inhibited by non-nucleoside analog RT inhibitors (NNRTIs) that bind in close proximity to the nucleotide binding site, highlighting the importance of (+)-strand initiation in the development of potent antivirals [54].”
BackgroundMarchand, B., & Götte, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304262200 · Cited by 106 · cited 2×
“Biochemical evidence suggests that RT can oscillate back and forth between pre- and post-translocational positions in a thermodynamic equilibrium that is sequence specific [34-38].”
BackgroundSelf-citationJulias, J. G., McWilliams, M. J., Sarafianos, S. G., Arnold, E., & Hughes, S. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.142123199 · Cited by 106 · cited 2×
“substrate on a trajectory that is conducive to RNase H cleavage [24,25].”
BackgroundCharacterization of the IL-6 Responsive Elements in the γ Fibrinogen Gene Promoter
Zhang, Z., Fuentes, N. L., & Fuller, G. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.41.24287 · Cited by 103
Archer, R. H., Dykes, C., Gerondelis, P., Lloyd, A., Fay, P., Reichman, R. C., Bambara, R. A., & Demeter, L. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.18.8390-8401.2000 · Cited by 99 · cited 2×
“NNRTI resistance mutation V106A showed a reduction in both 3’-end and 5’-end directed RNase H activity, which correlated with a decrease in viral fitness [66].”
BackgroundNucleotide-Induced Stable Complex Formation by HIV-1 Reverse Transcriptase
Tong, W., Lu, C., Sharma, S. K., Matsuura, S. E., So, A. G., & Scott, W. A. (1997) · Biochemistry · doi:10.1021/bi962410z · Cited by 97
Kirschberg, T. A., Balakrishnan, M., Squires, N. H., Barnes, T., Brendza, K. M., Chen, X., Eisenberg, E. J., Jin, W., Kutty, N., Leavitt, S., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900597q · Cited by 95 · cited 6×
“One of the pyrimidinol carboxylic acids was successful crystallized with Mn and the isolated HIV RNase H domain [85].”
BackgroundResultInfluentialActivation/Attenuation Model for RNase H
Keck, J. L., Goedken, E. R., & Marqusee, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.51.34128 · Cited by 93 · cited 1×
“coli RNase H1 which, in contrast to the 2-metal ion mechanism of HIV RNase H, uses a 1-metal ion activation/attenuation mechanism, further distancing itself from the active site inhibitors [16,97,98].”
BackgroundHachiya, A., Kodama, E. N., Sarafianos, S. G., Schuckmann, M. M., Sakagami, Y., Matsuoka, M., Takiguchi, M., Gatanaga, H., & Oka, S. (2008) · Journal of Virology · doi:10.1128/jvi.01154-07 · Cited by 93 · cited 2×
“AZT also selects for other connection/RNase H domain mutants such as A360I/V, A371V and Q509L [67-73].”
BackgroundBorkow, G., Fletcher, R. S., Barnard, J., Arion, D., Motakis, D., Dmitrienko, G. I., & Parniak, M. A. (1997) · Biochemistry · doi:10.1021/bi9624696 · Cited by 90 · cited 3×
“BBNH also failed to inhibit the RNase H activity of HIV-2 RT, which does not possess the NNRTI-binding pocket of HIV-1 RT [96].”
BackgroundGötte, M., Fackler, S., Hermann, T., Perola, E., Cellai, L., Gross, H. J., Grice, S. F. L., & Heumann, H. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07061.x · Cited by 89 · cited 3×
“, RNA-DNA/DNA hybrids are recognized differently by RT depending on the relative length of both the RNA and DNA portion of the primer [31].”
BackgroundSelf-citationEhteshami, M., Beilhartz, G. L., Scarth, B. J., Tchesnokov, E. P., McCormick, S. U., Wynhoven, B., Harrigan, P. R., & Götte, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m803521200 · Cited by 89
Self-citationBrehm, J. H., Koontz, D., Meteer, J. D., Pathak, V., Sluis-Cremer, N., & Mellors, J. W. (2007) · Journal of Virology · doi:10.1128/jvi.02203-06 · Cited by 85 · cited 3×
“AZT also selects for other connection/RNase H domain mutants such as A360I/V, A371V and Q509L [67-73].”
BackgroundDestefano, J. J., Mallaber, L. M., Fay, P. J., & Bambara, R. A. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.18.4330 · Cited by 82 · cited 1×
“Per definition, this specific cut is known as polymerase-dependent RNase H activity [21,28-32].”
BackgroundDelviks-Frankenberry, K. A., Nikolenko, G. N., Barr, R., & Pathak, V. K. (2007) · Journal of Virology · doi:10.1128/jvi.02820-06 · Cited by 81 · cited 1×
“Therefore, decreased RNase H activity could act to increase the half-life of the template, allowing more time for RT to excise AZT at the primer terminus [67,74-78].”
BackgroundHwang, C. K., Svarovskaia, E. S., & Pathak, V. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.221289898 · Cited by 80 · cited 2×
“Also, that in the context of (-)ssDNA strand transfer, both polymerase-dependent and – independent activities are required for completion of reverse transcription [59].”
BackgroundTrapping HIV-1 Reverse Transcriptase Before and After Translocation on DNA
Sarafianos, S. G., Clark, A. D., Tuske, S., Squire, C. J., Das, K., Sheng, D., Ilankumaran, P., Ramesha, A. R., Kroth, H., Sayer, J. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212911200 · Cited by 79 · cited 1×
“Biochemical evidence suggests that RT can oscillate back and forth between pre- and post-translocational positions in a thermodynamic equilibrium that is sequence specific [34-38].”
BackgroundRibonuclease H: properties, substrate specificity and roles in retroviral reverse transcription
Champoux, J. J., & Schultz, S. J. (2009) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.06909.x · Cited by 77 · cited 1×
“internally, or they depend on the precise positioning of the 5’-end of RNA fragments relative to the polymerase active site [42].”
BackgroundGao, H., Boyer, P. L., Arnold, E., & Hughes, S. H. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1624 · Cited by 77 · cited 1×
“The p51 thumb is in contact with the p66 RNase H domain, and mutations in this region have been known to affect RNase H activity [101,102].”
BackgroundShaw-Reid, C. A., Feuston, B., Munshi, V., Getty, K., Krueger, J., Hazuda, D. J., Parniak, M. A., Miller, M. D., & Lewis, D. (2005) · Biochemistry · doi:10.1021/bi0486740 · Cited by 76 · cited 2×
“an RNA-dependent DNA polymerase assay [95].”
BackgroundMurine leukemia virus reverse transcriptase: Structural comparison with HIV-1 reverse transcriptase
Coté, M. L., & Roth, M. J. (2008) · Virus Research · doi:10.1016/j.virusres.2008.01.001 · Cited by 75
Recent Progress in the Design of Small Molecule Inhibitors of HIV RNase H
Klumpp, K., & Mirzadegan, T. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873653 · Cited by 75
Marchand, B., Tchesnokov, E. P., & Götte, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607710200 · Cited by 74 · cited 1×
“Biochemical evidence suggests that RT can oscillate back and forth between pre- and post-translocational positions in a thermodynamic equilibrium that is sequence specific [34-38].”
BackgroundSelf-citationSmith, J. S., & Roth, M. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42147-3 · Cited by 73 · cited 1×
“In HIV-1 the tRNA primer is incompletely removed, with one rA:dT base pair remaining attached to the U5 terminus of the double-stranded DNA [56,61].”
BackgroundPullen, K. A., Ishimoto, L. K., & Champoux, J. J. (1992) · Journal of Virology · doi:10.1128/jvi.66.1.367-373.1992 · Cited by 72 · cited 2×
“In HIV-1 the tRNA primer is incompletely removed, with one rA:dT base pair remaining attached to the U5 terminus of the double-stranded DNA [56,61].”
BackgroundRausch, J. W., Lener, D., Miller, J. T., Julias, J. G., Hughes, S. H., & Le Grice, S. F. J. (2002) · Biochemistry · doi:10.1021/bi015970t · Cited by 71 · cited 1×
“Primer grip mutants also lower the rate of DNA synthesis and lower virus infectivity [25-27].”
BackgroundAptamers in the virologists' toolkit
James, W. (2007) · Journal of General Virology · doi:10.1099/vir.0.82442-0 · Cited by 70 · cited 1×
“DNA and RNA aptamers have recently been shown to be potent and selective inhibitors of HIV-1 RT, and its RNase H function, in cell-free assays [105-107].”
BackgroundSluis‐Cremer, N., Arion, D., & Parniak, M. A. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.398 · Cited by 67 · cited 11×
“It is possible that DHBNH shares the same two binding sites as BBNH.”
BackgroundInfluentialSantos, A. F., Lengruber, R. B., Soares, E. A., Jere, A., Sprinz, E., Martinez, A. M. B., Silveira, J. M., Sion, F. S., Pathak, V. K., & Soares, M. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001781 · Cited by 65 · cited 2×
“AZT also selects for other connection/RNase H domain mutants such as A360I/V, A371V and Q509L [67-73].”
BackgroundTwo defective forms of reverse transcriptase can complement to restore retroviral infectivity.
Telesnitsky, A., & Goff, S. P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06128.x · Cited by 63 · cited 1×
“Telesnitsky and Goff showed that MLV can successfully replicate when the polymerase and RNase H activities are provided on different enzymes, but again this system cannot completely discriminate between polymerase-dependent and –independent cuts, since polymerase-negative mutants could bind to the 3’-end of the primer…”
BackgroundFuentes, G. M., Rodríguez-Rodríguez, L., Fay, P. J., & Bambara, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28169 · Cited by 61 · cited 1×
“A purine-rich sequence (5’ AAAAGAAAAGGGGGG 3’) called the polypurine tract (PPT) located just 5’ to the U3 sequence of the genome is resistant to RNase H cleavage and remains intact after the rest of the viral RNA has been removed (RNase H makes a specific cut following the 6th “G” residue to define the 3’ end of the…”
BackgroundRadzio, J., & Sluis‐Cremer, N. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038596 · Cited by 61 · cited 1×
“Therefore, decreased RNase H activity could act to increase the half-life of the template, allowing more time for RT to excise AZT at the primer terminus [67,74-78].”
BackgroundPalaniappan, C., Fay, P. J., & Bambara, R. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4861 · Cited by 61 · cited 1×
“A purine-rich sequence (5’ AAAAGAAAAGGGGGG 3’) called the polypurine tract (PPT) located just 5’ to the U3 sequence of the genome is resistant to RNase H cleavage and remains intact after the rest of the viral RNA has been removed (RNase H makes a specific cut following the 6th “G” residue to define the 3’ end of the…”
BackgroundCrystal Structure of the Moloney Murine Leukemia Virus RNase H Domain
Lim, D., Gregorio, G. G., Bingman, C., Martinez-Hackert, E., Hendrickson, W. A., & Goff, S. P. (2006) · Journal of Virology · doi:10.1128/jvi.00750-06 · Cited by 60 · cited 10×
“In HIV-1 RT, the connection subdomain contains a small loop (residues K353 to T365) that contains several basic residues and is structurally located at the exact position of the E. coli and MLV basic loops, and is thought to compensate for the lack of the C-helix [8,12] since RNase H activity was restored to an inacti…”
BackgroundInfluentialWendeler, M., Lee, H.-F., Bermingham, A., Miller, J. T., Chertov, O., Bona, M. K., Baichoo, N. S., Ehteshami, M., Beutler, J., O’Keefe, B. R., et al. (2008) · ACS Chemical Biology · doi:10.1021/cb8001039 · Cited by 59 · cited 6×
“The effects of the inhibitor on primer grip mutants support the hypothesis that NSC727447 binds near the p51 thumb.”
BackgroundInfluentialSelf-citationModulation of HIV-1 reverse transcriptase function in “selectively deleted” p66/p51 heterodimers.
Jacques, P. S., Wöhrl, B. M., Howard, K. J., & Le Grice, S. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42270-8 · Cited by 59 · cited 1×
“The p51 thumb is in contact with the p66 RNase H domain, and mutations in this region have been known to affect RNase H activity [101,102].”
BackgroundDelviks-Frankenberry, K. A., Nikolenko, G. N., Boyer, P. L., Hughes, S. H., Coffin, J. M., Jere, A., & Pathak, V. K. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804660105 · Cited by 59 · cited 1×
“Therefore, decreased RNase H activity could act to increase the half-life of the template, allowing more time for RT to excise AZT at the primer terminus [67,74-78].”
BackgroundBeilhartz, G. L., Wendeler, M., Baichoo, N., Rausch, J., Le Grice, S., & Götte, M. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.03.025 · Cited by 58 · cited 10×
“The order-of-addition data also show that the substrate is eventually cleaved to the same level as without inhibitor, suggesting that the substrate binds tighter and will eventually displace β-thujaplicinol in the RNase H active site [39].”
BackgroundMethodResultInfluentialSelf-citationTemporal Coordination between Initiation of HIV (+)-Strand DNA Synthesis and Primer Removal
Götte, M., Maier, G., Onori, A. M., Cellai, L., Wainberg, M. A., & Heumann, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.11159 · Cited by 56 · cited 2×
“A purine-rich sequence (5’ AAAAGAAAAGGGGGG 3’) called the polypurine tract (PPT) located just 5’ to the U3 sequence of the genome is resistant to RNase H cleavage and remains intact after the rest of the viral RNA has been removed (RNase H makes a specific cut following the 6th “G” residue to define the 3’ end of the…”
BackgroundSelf-citationActivity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides
Hang, J. Q., Rajendran, S., Yang, Y., Li, Y., Wong-Kai-In, P., Overton, H. A., Parkes, K. E. B., Cammack, N., Martin, J. A., & Klumpp, K. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.03.061 · Cited by 56 · cited 2×
“Developed from influenza inhibitors and among the first to use the 3-oxygen pharmacophore [84].”
BackgroundGötte, M., Maier, G., Gross, H. J., & Heumann, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.17.10139 · Cited by 56 · cited 13×
“This likely contributes to tighter enzyme binding to RNA/DNA than DNA/DNA [22].”
BackgroundInfluentialSelf-citationInhibitory effects of quinones on RNase H activity associated with HIV-1 reverse transcriptase
Min, B.-S., Miyashiro, H., & Hattori, M. (2002) · Phytotherapy Research · doi:10.1002/ptr.808 · Cited by 53 · cited 1×
“There have been many other compounds described in the literature that show apparent inhibition of RNase H activity, including natural products such as various quinones and napthoquinone derivatives, although many of these suffer from a lack of potency [103,104].”
BackgroundJulias, J. G., McWilliams, M. J., Sarafianos, S. G., Alvord, W. G., Arnold, E., & Hughes, S. H. (2003) · Journal of Virology · doi:10.1128/jvi.77.15.8548-8554.2003 · Cited by 53 · cited 1×
“substrate on a trajectory that is conducive to RNase H cleavage [24,25].”
BackgroundKeck, J. L., & Marqusee, S. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2740 · Cited by 52 · cited 1×
“inactive HIV-1 RNase H domain, Mn-dependent activity is partially restored [14].”
BackgroundPlus-strand origin for human immunodeficiency virus type 1: implications for integration
Pullen, K. A., & Champoux, J. J. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.6274-6277.1990 · Cited by 50 · cited 1×
“A purine-rich sequence (5’ AAAAGAAAAGGGGGG 3’) called the polypurine tract (PPT) located just 5’ to the U3 sequence of the genome is resistant to RNase H cleavage and remains intact after the rest of the viral RNA has been removed (RNase H makes a specific cut following the 6th “G” residue to define the 3’ end of the…”
BackgroundMutational Analysis of Tyr-501 of HIV-1 Reverse Transcriptase
Arion, D., Sluis-Cremer, N., Min, K.-L., Abram, M. E., Fletcher, R. S., & Parniak, M. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110254200 · Cited by 50 · cited 2×
“Modeling studies have suggested that Y501 is important for BBNH binding [100].”
BackgroundResultGutiérrez‐Rivas, M., & Menéndez-Arias, L. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.24.4963 · Cited by 44 · cited 1×
“Primer grip mutants also lower the rate of DNA synthesis and lower virus infectivity [25-27].”
BackgroundCane, P. A., Green, H., Fearnhill, E., & Dunn, D. T. (2007) · AIDS · doi:10.1097/qad.0b013e3280129964 · Cited by 43 · cited 2×
“AZT also selects for other connection/RNase H domain mutants such as A360I/V, A371V and Q509L [67-73].”
BackgroundNtemgwa, M. L., Wainberg, M. A., Oliveira, M., Moisi, D. D., LALONDE, R. G., Micheli, V., & BRENNER, B. G. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00646-07 · Cited by 43 · cited 2×
“AZT also selects for other connection/RNase H domain mutants such as A360I/V, A371V and Q509L [67-73].”
BackgroundSmith, J. S., Gritsman, K., & Roth, M. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5721-5729.1994 · Cited by 42 · cited 1×
“thought to compensate for the lack of the C-helix [8,12] since RNase H activity was restored to an inactive isolated domain with the addition of the p66 connection domain in trans [15].”
BackgroundWöhrl, B. M., Volkmann, S., & Moelling, K. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90119-q · Cited by 42 · cited 1×
“Per definition, this specific cut is known as polymerase-dependent RNase H activity [21,28-32].”
BackgroundSevilya, Z., Loya, S., Adir, N., & Hizi, A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg235 · Cited by 40 · cited 1×
“This discrepancy in activity has been shown to be due to a single residue (Q294) in the catalytically inactive p54 subunit, which is the structural equivalent of the p51 subunit in HIV-1 RT [19,20].”
BackgroundHachiya, A., Shimane, K., Sarafianos, S. G., Kodama, E. N., Sakagami, Y., Negishi, F., Koizumi, H., Gatanaga, H., Matsuoka, M., Takiguchi, M., et al. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.02.189 · Cited by 40 · cited 1×
“The RNase H mutant Q509L likely operates in a similar mechanism, although it appears only rarely in therapy-experienced patient [67,80,81].”
BackgroundRecognition of Internal Cleavage Sites by Retroviral RNases H
Schultz, S. J., Zhang, M., & Champoux, J. J. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.09.081 · Cited by 40 · cited 1×
“effect these sequence preferences may have and how it specifically directs RNase H cleavages is as yet unknown [43].”
BackgroundJulias, J. G., McWilliams, M. J., Sarafianos, S. G., Alvord, W. G., Arnold, E., & Hughes, S. H. (2004) · Journal of Virology · doi:10.1128/jvi.78.23.13315-13324.2004 · Cited by 40 · cited 1×
“PPT primers with aberrant cleavages or that improperly begin DNA synthesis are not used efficiently and reverse transcription does not proceed [53].”
BackgroundInsights into the Multiple Roles of Pausing in HIV-1 Reverse Transcriptase-promoted Strand Transfers
Gao, L., Balakrishnan, M., Roques, B. P., & Bambara, R. A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610056200 · Cited by 38 · cited 1×
“is arrested, with chain terminating nucleotides for example, strand transfer rates increase [57].”
BackgroundKissel, J. D., Held, D. M., Hardy, R. W., & Burke, D. H. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0262 · Cited by 38 · cited 1×
“DNA and RNA aptamers have recently been shown to be potent and selective inhibitors of HIV-1 RT, and its RNase H function, in cell-free assays [105-107].”
BackgroundTsunaka, Y., Takano, K., Matsumura, H., Yamagata, Y., & Kanaya, S. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.11.007 · Cited by 36
Schultz, S. J., Zhang, M., & Champoux, J. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510504200 · Cited by 35 · cited 1×
“Cleavages of this type occur in a “cleavage window” of approximately 13-19 nucleotides from the 5’ termini of the RNA fragment [45].”
BackgroundKeck, J. L., & Marqusee, S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19883 · Cited by 34 · cited 1×
“coli inhibits but does not abolish activity [13], although the isolated RNase H domain of MLV with the basic loop deleted is not active [8].”
BackgroundGötte, M. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206776873626 · Cited by 32 · cited 2×
“Biochemical evidence suggests that RT can oscillate back and forth between pre- and post-translocational positions in a thermodynamic equilibrium that is sequence specific [34-38].”
BackgroundSelf-citationBrehm, J. H., Mellors, J. W., & Sluis‐Cremer, N. (2008) · Biochemistry · doi:10.1021/bi8014778 · Cited by 32 · cited 1×
“The RNase H mutant Q509L likely operates in a similar mechanism, although it appears only rarely in therapy-experienced patient [67,80,81].”
BackgroundEhteshami, M., & Götte, M. (2008) · PubMed · Cited by 28
Self-citationAcceptor RNA Cleavage Profile Supports an Invasion Mechanism for HIV-1 Minus Strand Transfer
Chen, Y., Balakrishnan, M., Roques, B. P., & Bambara, R. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412190200 · Cited by 25
Hannoush, R. N., Carriero, S., Min, K., & Damha, M. J. (2004) · ChemBioChem · doi:10.1002/cbic.200300831 · Cited by 23 · cited 1×
“DNA and RNA aptamers have recently been shown to be potent and selective inhibitors of HIV-1 RT, and its RNase H function, in cell-free assays [105-107].”
BackgroundBohlayer, W. P., & DeStefano, J. J. (2006) · Biochemistry · doi:10.1021/bi051770w · Cited by 20 · cited 5×
“This likely contributes to tighter enzyme binding to RNA/DNA than DNA/DNA [22].”
BackgroundInfluentialSchultz, S. J., Zhang, M., & Champoux, J. J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.043158 · Cited by 17 · cited 1×
“-4, -2 and +1 (where the scissile phosphate is between positions -1 and +1, and negative and positive positions proceed 5’ and 3’ from the scissile phosphate, respectively) [46].”
BackgroundGötte, M. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040346 · Cited by 17 · cited 3×
“AZT also selects for other connection/RNase H domain mutants such as A360I/V, A371V and Q509L [67-73].”
BackgroundSelf-citationOh, J., McWilliams, M. J., Julias, J. G., & Hughes, S. H. (2007) · Journal of Virology · doi:10.1128/jvi.02611-06 · Cited by 16 · cited 2×
“This is perhaps not surprising since the related RNase H from HIV-2 normally removes three nucleotides before the CA dinucleotide [63].”
BackgroundBochner, R., Duvshani, A., Adir, N., & Hizi, A. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.07.010 · Cited by 7 · cited 5×
“P294 is seen in approximately 80% of sequenced isolates of HIV-1, while Q294 appears only about 1% of the time in HIV-1 and the recombinant mutant shows reduced RNase H activity [19].”
BackgroundResultInfluential
Research works printed but not linked: 1
- Telesnitsky, A., and Goff, S. (1997). Cold Spring Harbor Laboratory Press.
Cited by
Menéndez-Arias, L. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.01.007 · Cited by 207
RNases H: Structure and mechanism
Hyjek, M., Figiel, M., & Nowotny, M. (2019) · DNA Repair · doi:10.1016/j.dnarep.2019.102672 · Cited by 160
Vernekar, S. K. V., Liu, Z., Nagy, E., Miller, L., Kirby, K. A., Wilson, D. J., Kankanala, J., Sarafianos, S. G., Parniak, M. A., & Wang, Z. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm501132s · Cited by 137
Menéndez-Arias, L., Sebastián-Martín, A., & Álvarez, M. (2017) · Virus Research · doi:10.1016/j.virusres.2016.12.019 · Cited by 123
Esposito, F., Corona, A., & Tramontano, E. (2012) · Molecular Biology International · doi:10.1155/2012/586401 · Cited by 138
“This action occurs through the deprotonation of a water molecule, with the production of a nucleophilic hydroxide group that attacks the scissile phosphate group on the RNA previously activated by coordination with the Mg cofactor [24].”
Background
Metadata
- Authors
- Beilhartz, G. L., & Götte, M.
- Affiliations
- McGill University (CA)
- Corresponding author
- Götte, Matthias
- Venue
- Viruses
- Publisher
- MDPI AG
- Published
- 2010-03-30
- Volume
- 2
- Issue
- 4
- Pages
- 900-926
- ISSN
- 1999-4915 (ISSN-L)
- PMC
- PMC3185654
- OpenAlex
- W2025259834
- Cited by
- 88
- References
- 108
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 6 · 2023: 4 · 2022: 7 · 2021: 8 · 2020: 4 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 6 · 2015: 2 · 2014: 3 · 2013: 6 · 2012: 8
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Viruses (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIV-1, RNase H, reverse transcriptase, catalytic mechanism, enzyme structure, structure-function relationship, RNase H inhibitors, antiviral drug discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.